New framework reframes canine corneal ulcer management
Bottom line
VERSION 1 — BRIEF
A new review in Frontiers in Veterinary Science argues that canine corneal ulcer management should move beyond a mainly morphology-based, anticollagenase-first mindset and instead use a mechanism-based framework built around five domains: structural preservation, inflammatory modulation, regenerative augmentation, functional optimization, and precision stratification. Author Takuya Yogo positions structural preservation as the top priority during active stromal melting, but says ulcer progression is also shaped by inflammatory amplification, impaired epithelial healing, tear-film and ocular surface dysfunction, and patient-level risk factors such as brachycephalic conformation and neurotrophic deficits. The paper was published June 19, 2026, and presents the model as a conceptual hierarchy rather than a validated treatment algorithm. (frontiersin.org)
Why it matters: For general practitioners and ophthalmology teams, the paper offers a more organized way to think through why some ulcers worsen despite standard therapy. That may be especially useful in cases that don’t fit neatly into “simple,” “melting,” or “indolent” categories. Existing clinical guidance still supports urgent escalation for deep, melting, or perforation-risk ulcers, including referral and possible grafting, while common causes of delayed healing can include tear-film disease, exposure, adnexal abnormalities, infection, and spontaneous chronic corneal epithelial defects. Yogo’s framework doesn’t replace those basics, but it may help clinicians match adjunctive choices to the dominant biologic driver instead of reflexively rotating medications. (cliniciansbrief.com)
What to watch: The next question is whether canine-specific prospective studies can validate domain-based treatment pathways and produce practical stratification tools for use in first-opinion practice and referral settings. (researchgate.net)
Key facts
- Article type
- Conceptual review
- Journal
- Frontiers in Veterinary Science
- Publication date
- June 19, 2026
- Author
- Takuya Yogo
- Topic
- Canine corneal ulcer progression and adjunctive management
- Framework
- Five domains: structural preservation, inflammatory modulation, regenerative augmentation, functional optimization, and precision stratification
- Top priority during active stromal melting
- Structural preservation
- Main limitation
- Not a clinical trial or validated treatment algorithm
VERSION 2 — FULL ANALYSIS
A new Frontiers in Veterinary Science review is proposing a different way to think about canine corneal ulcers: not just by how they look, but by which biologic processes are actually driving progression. In “Mechanistic domains in canine corneal ulcer progression: a conceptual framework for adjunctive management,” published June 19, 2026, Takuya Yogo outlines a five-domain model meant to guide adjunctive therapy around the dominant pathophysiology in each case. (frontiersin.org)
That’s a notable shift because adjunctive management has long centered on protease inhibition and visible severity, especially in melting ulcers. Yogo does not argue against that standard. Instead, the review explicitly preserves structural preservation, including anticollagenase logic, as the highest-priority domain during active stromal melting because the immediate goal is to prevent irreversible tissue loss. But the paper argues that ulcer progression is rarely a single-process event, and that inflammation, failed epithelial repair, ocular surface dysfunction, and host-specific risk factors can all shape outcomes at the same time. (researchgate.net)
The framework organizes care into five domains: structural preservation, inflammatory modulation, regenerative augmentation, functional optimization, and precision stratification. According to the review, structural preservation has the strongest canine clinical evidence, while the other domains are supported more unevenly, often by limited canine data, translational studies, or emerging technologies. The paper describes this as a dynamic hierarchy rather than a fixed sequence, meaning multiple domains may be relevant in the same patient depending on whether the main problem is active collagenolysis, maladaptive inflammation, poor epithelial adhesion, or a compromised tear film and ocular surface. (researchgate.net)
That framing lines up with how ophthalmologists already describe the complexity of nonhealing and complicated ulcers. ACVO public guidance notes that ulcers not healing appropriately or extending deep into the stroma warrant ophthalmology evaluation. Clinician-focused resources similarly emphasize that deep ulcers, descemetoceles, and perforations may require surgery, including conjunctival or collagen grafting, while chronic nonhealing ulcers often reflect underlying issues such as keratoconjunctivitis sicca, exposure, adnexal disease, foreign bodies, or SCCED rather than a need to simply switch antibiotics. In a 2025 dvm360 interview, ophthalmologist Alex Sigmund said antibiotics don’t heal ulcers themselves and warned against repeatedly changing drugs when infection hasn’t been identified, a point that echoes the paper’s push to treat the dominant mechanism rather than the most obvious surface finding. (acvo.org)
The review also lands amid broader interest in adjunctive and regenerative approaches in veterinary ophthalmology, though the evidence base remains mixed. Recent Frontiers work has looked at commercial amniotic membrane extract eye drops for canine SCCED, while the references cited in related literature include studies on heterologous serum, platelet-rich plasma, tetracycline-class adjuncts, bandage contact lenses, diamond burr debridement, and superficial keratectomy. That backdrop helps explain the value of a framework that separates established, canine-supported interventions from lower-evidence or investigational options. (frontiersin.org)
Why it matters: For veterinary professionals, especially GPs managing urgent eye cases before referral, this paper offers a more usable mental model for triage and adjunctive decision-making. It reinforces that “corneal ulcer” is not one biologic problem. A melting ulcer threatening perforation, an indolent SCCED, and a painful ulcer complicated by tear-film instability may all need different priorities even if fluorescein staining is positive in each case. In practice, that could support more deliberate decisions about when to focus on structural rescue, when to search harder for tear-film or conformational contributors, and when a lack of healing should prompt reassessment of mechanism instead of medication churn. (researchgate.net)
The paper’s main limitation is that it is a conceptual review, not a clinical trial or consensus guideline. Yogo acknowledges that canine-specific validation is still needed, particularly for precision stratification and for domains outside structural preservation, where the evidence is thinner. So the immediate takeaway is not that clinicians should replace established ulcer protocols, but that they may benefit from layering a biologic framework onto them, particularly in refractory, mixed-mechanism, or fast-evolving cases. (researchgate.net)
What to watch: Watch for prospective canine studies that test whether domain-based treatment selection improves healing times, reduces perforation risk, or sharpens referral timing, and for any practical tools that help first-opinion veterinarians identify the dominant driver at the point of care. (researchgate.net)